[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632473":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":69,"collaborators":10,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":10,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":10,"enrollmentInfo":80,"targetDuration":10,"studyType":83,"phases":10,"briefSummary":84,"conditions":85,"keywords":88,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Nucleix Ltd.","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Subjects planned to undergo TURBT due to suspected or detected bladder tumor",null,"Adult subjects planned to undergo TURBT within 60 days due to suspected or detected bladder tumor (e.g., by cystoscopy, cytology, imaging) will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.",[13],"Diagnostic Test: Bladder EpiCheck",{"label":15,"type":10,"description":16,"interventionNames":17},"Subjects planned to undergo cystoscopy under general anesthesia due to suspected bladder tumor","Adult subjects planned to undergo cystoscopy under general anesthesia ,within 60 days due to suspected bladder tumor will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Subjects planned to undergo cystoscopy for NMIBC surveillance","Adult subjects planned to undergo cystoscopy for NMIBC surveillance ,within 60 days will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DIAGNOSTIC_TEST","Bladder EpiCheck","Methylation biomarker urine test",[9,19,15],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Limor Klein, PhD","CONTACT","+972-8-9161616","limor.k@nucleix.com",[35,54],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Om Research LLC","RECRUITING","San Diego","California","92103","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-117.16472,32.71571,{"lat":47,"lon":46},[50],{"name":51,"role":31,"phone":52,"phoneExt":10,"email":53},"Gavriushina","858.429.7050","agavriushina@omclinicaltrials.com",{"facility":55,"status":37,"city":56,"state":57,"zip":58,"country":41,"countryCode":42,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Chesapeake Urology Research Associates","Towson","Maryland","21204",{"type":44,"coordinates":60},[61,62],-76.60191,39.4015,{"lat":62,"lon":61},[65],{"name":66,"role":31,"phone":67,"phoneExt":10,"email":68},"Phelps","410-205-8590","stephanie.phelps@chesuro.com",{"type":70,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100632473","bladder-epicheck-product-development-study-100632473",false,"NCT07514143","Bladder EpiCheck Product Development Study","Collection of Urine Samples to Support the Bladder EpiCheck Product Development Studies","Inclusion Criteria:\n\n1. Age 22 or older\n2. Willing and able to sign the informed consent form\n3. Subject(s) that is planned to undergo ,within 60 days, one of the following procedures:\n\n3.1 TURBT due to suspected or detected bladder tumor, or 3.2 Cystoscopy under general anesthesia due to suspected bladder tumor, or 3.3 Cystoscopy for NMIBC surveillance\n\nExclusion Criteria:\n\n1. Patients with known or history of muscle invasive bladder cancer (MIBC)\n2. Treatment of prostate cancer or RCC in the past 2 years\n3. Patients previously enrolled into this study within the prior 60 days","ALL","22 Years",{"count":81,"type":82},1000,"ESTIMATED","OBSERVATIONAL","This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance.\n\nThis is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.",[86,87],"Suspicion of Bladder Cancer","NMIBC Surveillance",[89,90],"EpiCheck","Bladder cancer","2026-04-05",{"date":93,"type":94},"2026-04-07","ACTUAL",{"date":96,"type":94},"2025-09-15",{"date":98,"type":82},"2026-12",{"name":5,"class":6},2]